India ·
General Atlantic sells an 8.4% Rubicon Research stake for ₹2,300cr, more than 3x the drugmaker's ₹485 IPO price
Majority owner General Atlantic Singapore RR sold a little over 8.4% of formulations maker Rubicon Research — roughly 1.47 crore shares, worth about ₹2,300 crore or near ₹1,560 apiece — into an August 26 block deal taken up by HDFC, ICICI Prudential, Kotak and SBI mutual funds plus Temasek's Aranda Investments, cashing out at more than three times the ₹485 price of the company's October 2025 IPO and lifting the stock about 6%.
Source: Business Standard ↗
Frequently asked questions
Is this an original report, or a copy of the source article?
This is original commentary and context written for this site, citing Business Standard as the source. Read the full original reporting at the source link below.
How current is this information?
This item reflects reporting as of 26 August 2026. Secondary-market situations like this one can change quickly — check the source link for the latest developments.